TMEM130 antibody
Principal name
TMEM130 antibody
Alternative names for TMEM130 antibody
Transmembrane protein 130
Ncbi ID
NM_177735, NP_690877.1, NP_690877, NP_001127922.1, NP_808403.2, NM_152913, NM_001134450
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of TMEM130 antibody
- Kit Component:
- - KN317715G1, Tmem130 gRNA vector 1 in pCas-Guide vector
- KN317715G2, Tmem130 gRNA vector 2 in pCas-Guide vector
- KN317715D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Mouse Muscle; WB Suggested Anti-Tmem130 Antibody Titration: 0.2-1 ug/ml. Positive Control: Mouse Muscle; Tmem130 antibody - C-terminal region (ARP37573_P050) in Mouse Muscle cells using Western Blot
Mouse Thymus; WB Suggested Anti-Tmem130 Antibody Titration: 0.2-1 ug/ml. Positive Control: Mouse Thymus; Tmem130 antibody - middle region (ARP37574_P050) in Mouse Thymus cells using Western Blot
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP306371 | TMEM130 (transcript variant 2) |
||||
| Recombinant protein of human transmembrane protein 130 (TMEM130), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR206660L2V | Lenti ORF particles, Tmem130 (GFP-tagged) - Mouse transmembrane protein 130 (Tmem130), 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR206660L1V | Lenti ORF particles, Tmem130 (Myc-DDK-tagged) - Mouse transmembrane protein 130 (Tmem130), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
